Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Appraisal and Valuation : Contemporary Issues and New Frontiers / / edited by Pierluigi Morano, Alessandra Oppio, Paolo Rosato, Leopoldo Sdino, Francesco Tajani
| Appraisal and Valuation : Contemporary Issues and New Frontiers / / edited by Pierluigi Morano, Alessandra Oppio, Paolo Rosato, Leopoldo Sdino, Francesco Tajani |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (IX, 337 p. 78 illus., 52 illus. in color.) |
| Disciplina | 332.63221 |
| Collana | Green Energy and Technology |
| Soggetto topico |
Regional economics
Space in economics Facility management Urban geography Regional/Spatial Science Facility Management Urban Geography / Urbanism (inc. megacities, cities, towns) |
| ISBN | 3-030-49579-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Territory & Urban Planning -- Real Estate Assets & Construction Building Process -- Real Estate Finance & Property Management. |
| Record Nr. | UNINA-9910484313003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotechnology valuation [[electronic resource] ] : an introductory guide / / Karl D. Keegan
| Biotechnology valuation [[electronic resource] ] : an introductory guide / / Karl D. Keegan |
| Autore | Keegan Karl D |
| Pubbl/distr/stampa | Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina |
332.63221
380.1456606 |
| Collana | Wiley finance |
| Soggetto topico |
Biotechnology industries - Valuation
Pharmaceutical industry - Valuation Investment analysis |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-118-67350-6
1-282-34938-4 9786612349386 0-470-74134-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotechnology Valuation; Contents; Acknowledgements; 1 Introduction; Biotechnology Background; 2 Traditional Valuation Methods; The Value of a Company; Accounts - Providing the Data for Valuation Analysis; The Income Statement; Balance Sheet; Cash Flow Statement; Income Statement Multiples; Balance Sheet Multiples; Summary; Discounted Cash Flow Analysis; Net Present Value; Constructing the DCF; Projecting the Cash Flow Stream; Choosing a Discount Rate; Other Thoughts; 3 The Drug Development Process; The Drug Development Process; Drug Discovery and Research; Pre-Clinical Development
Clinical TrialsWhat Investors Should Look For When Analysing Clinical Trials; Conclusion; The Regulatory Process; Regulation in the US; Regulation in Europe; The Label; Timelines for Approval; Post Approval; Investment Lessons; Case Study #1; 4 Biotechnology Company Valuation; Data Collation; NPV of the Pipeline; Calculations; Sensitivity Analyses; DCF of Whole Company; EBIT DCF of Products; Comparables Valuation; NPVs are Additive; Using all the Tools Available to Reach a Valuation Conclusion; Market Models; Conclusion; Appendix 1; Example 1; Example 2; Example 3; Appendix 2 Biosimilar Update5 Decision Trees and Real Options; Decision Trees; Discount Rate; Deriving Scenarios; Conclusion; Decision Tree Example; Real Options; Valuing Options; Estimation of the Input Variables; Conclusions; 6 Biotechnology Investing; Types of Healthcare Investment; Biotechnology Sector Evolution; Biotechnology Investment Cycles; Biotechnology Business Models; Focus on People; Cash; Product Pipeline; Commercial Risks; Newsflow; Lessons from Biotech Investing; 7 Early-stage Valuation; Private Valuation; Discounted Cash Flow Method; Comparable Valuation; Venture Capital Method Discount RatesConclusion; Glossary; References; Index |
| Record Nr. | UNINA-9910145260003321 |
Keegan Karl D
|
||
| Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotechnology valuation [[electronic resource] ] : an introductory guide / / Karl D. Keegan
| Biotechnology valuation [[electronic resource] ] : an introductory guide / / Karl D. Keegan |
| Autore | Keegan Karl D |
| Pubbl/distr/stampa | Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina |
332.63221
380.1456606 |
| Collana | Wiley finance |
| Soggetto topico |
Biotechnology industries - Valuation
Pharmaceutical industry - Valuation Investment analysis |
| ISBN |
1-118-67350-6
1-282-34938-4 9786612349386 0-470-74134-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotechnology Valuation; Contents; Acknowledgements; 1 Introduction; Biotechnology Background; 2 Traditional Valuation Methods; The Value of a Company; Accounts - Providing the Data for Valuation Analysis; The Income Statement; Balance Sheet; Cash Flow Statement; Income Statement Multiples; Balance Sheet Multiples; Summary; Discounted Cash Flow Analysis; Net Present Value; Constructing the DCF; Projecting the Cash Flow Stream; Choosing a Discount Rate; Other Thoughts; 3 The Drug Development Process; The Drug Development Process; Drug Discovery and Research; Pre-Clinical Development
Clinical TrialsWhat Investors Should Look For When Analysing Clinical Trials; Conclusion; The Regulatory Process; Regulation in the US; Regulation in Europe; The Label; Timelines for Approval; Post Approval; Investment Lessons; Case Study #1; 4 Biotechnology Company Valuation; Data Collation; NPV of the Pipeline; Calculations; Sensitivity Analyses; DCF of Whole Company; EBIT DCF of Products; Comparables Valuation; NPVs are Additive; Using all the Tools Available to Reach a Valuation Conclusion; Market Models; Conclusion; Appendix 1; Example 1; Example 2; Example 3; Appendix 2 Biosimilar Update5 Decision Trees and Real Options; Decision Trees; Discount Rate; Deriving Scenarios; Conclusion; Decision Tree Example; Real Options; Valuing Options; Estimation of the Input Variables; Conclusions; 6 Biotechnology Investing; Types of Healthcare Investment; Biotechnology Sector Evolution; Biotechnology Investment Cycles; Biotechnology Business Models; Focus on People; Cash; Product Pipeline; Commercial Risks; Newsflow; Lessons from Biotech Investing; 7 Early-stage Valuation; Private Valuation; Discounted Cash Flow Method; Comparable Valuation; Venture Capital Method Discount RatesConclusion; Glossary; References; Index |
| Record Nr. | UNINA-9910830979303321 |
|
Keegan Karl D
|
||
| Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotechnology valuation : an introductory guide / / Karl D. Keegan
| Biotechnology valuation : an introductory guide / / Karl D. Keegan |
| Autore | Keegan Karl D |
| Pubbl/distr/stampa | Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina |
332.63221
380.1456606 |
| Collana | Wiley finance |
| Soggetto topico |
Biotechnology industries - Valuation
Pharmaceutical industry - Valuation Investment analysis |
| ISBN |
1-118-67350-6
1-282-34938-4 9786612349386 0-470-74134-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotechnology Valuation; Contents; Acknowledgements; 1 Introduction; Biotechnology Background; 2 Traditional Valuation Methods; The Value of a Company; Accounts - Providing the Data for Valuation Analysis; The Income Statement; Balance Sheet; Cash Flow Statement; Income Statement Multiples; Balance Sheet Multiples; Summary; Discounted Cash Flow Analysis; Net Present Value; Constructing the DCF; Projecting the Cash Flow Stream; Choosing a Discount Rate; Other Thoughts; 3 The Drug Development Process; The Drug Development Process; Drug Discovery and Research; Pre-Clinical Development
Clinical TrialsWhat Investors Should Look For When Analysing Clinical Trials; Conclusion; The Regulatory Process; Regulation in the US; Regulation in Europe; The Label; Timelines for Approval; Post Approval; Investment Lessons; Case Study #1; 4 Biotechnology Company Valuation; Data Collation; NPV of the Pipeline; Calculations; Sensitivity Analyses; DCF of Whole Company; EBIT DCF of Products; Comparables Valuation; NPVs are Additive; Using all the Tools Available to Reach a Valuation Conclusion; Market Models; Conclusion; Appendix 1; Example 1; Example 2; Example 3; Appendix 2 Biosimilar Update5 Decision Trees and Real Options; Decision Trees; Discount Rate; Deriving Scenarios; Conclusion; Decision Tree Example; Real Options; Valuing Options; Estimation of the Input Variables; Conclusions; 6 Biotechnology Investing; Types of Healthcare Investment; Biotechnology Sector Evolution; Biotechnology Investment Cycles; Biotechnology Business Models; Focus on People; Cash; Product Pipeline; Commercial Risks; Newsflow; Lessons from Biotech Investing; 7 Early-stage Valuation; Private Valuation; Discounted Cash Flow Method; Comparable Valuation; Venture Capital Method Discount RatesConclusion; Glossary; References; Index |
| Record Nr. | UNINA-9910877522303321 |
|
Keegan Karl D
|
||
| Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Corporate valuation for portfolio investment : analyzing assets, earnings, cash flow, stock price, governance, and special situations / / Robert A. G. Monks, Alexandra Reed Lajoux ; Foreword by Dean LaBaron
| Corporate valuation for portfolio investment : analyzing assets, earnings, cash flow, stock price, governance, and special situations / / Robert A. G. Monks, Alexandra Reed Lajoux ; Foreword by Dean LaBaron |
| Autore | Monks Robert A. G. |
| Edizione | [1st edition] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Bloomberg Press, , 2011 |
| Descrizione fisica | 1 online resource (579 p.) |
| Disciplina |
332.63221
658.15 |
| Collana | Bloomberg Financial |
| Soggetto topico |
Corporations - Valuation
Portfolio management |
| ISBN |
1-282-84905-0
1-283-10047-9 1-118-53186-8 9786612849053 9786613100474 1-118-02645-4 1-118-02646-2 0-470-88074-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Corporate Valuation for Portfolio Investment: Analyzing Assets, Earnings, Cash Flow, Stock Price, Governance, and Special Situations; Contents; Foreword; Preface; Acknowledgments; Chapter 1: Corporate Valuation for Portfolio Investment; Valuation Defined; The Importance of Equity; Equity Defined; Articles of Faith Undermined: Securitization at Risk; Benefits of the Equity Marketplace; The Flexible Nature of Equity Capital; Long-Term Superiority of Equity over Debt-with a Caution about Volatility; The Focused Nature of Valuation for Investment; Two Main Sources of Information about Equity
Financial Reports: Issues with GAAP and IFRS/IASSources of Complexity in Accounting for Company Value; Reforming GAAP and IFRS; The Problem of Fair Market Value: Reporting Values for Securities with No Current Market; Three Studies; The Need to Read between the Lines; Human Nature Complicates (but Also Informs) Equity Valuation; George Soros's Concept of Reflexivity; Other Paradoxes in Equity Investing; The Observer Effect; Human Nature as the Key to Equity Value; Need for Expression in Currency Values; On Financial Mathematics; In Closing: About This Book; A Range of Approaches; Notes Chapter 2: Valuation Based on AssetsOverview of Assets as a Unit of Valuation; An Opening Caveat: The Limitations of Accounting Numbers; Accounting Numbers: Why Assets as a Starting Point?; Definition of an Asset; Flow-Dominant vs. Value-Dominant Assets; The Market Premium and Nonmarket Discount; Bear Stearns: A Cautionary Tale; The Asset-Focused Investor; Current Asset Value; Taking Clues from Assets; The Sykes Model; Beyond Assets: Clues from Liabilities and Equity on the Balance Sheet; The Role of the Appraiser and Appraisal Standards in Valuing Assets; Fair Market Value Treatment Assets Fair Value of Assets Under FASB (GAAP) and IASB (IFRS)Valuing Intangible Assets on the Balance Sheet; Valuing Intangible Assets That Are Not on the Balance Sheet; Using the MD&A for Insights on Assets; Improvements in Fair Value Disclosures: A Checklist for Investors; Asset-Based Valuation by Industry; Special Topics in Asset Valuations: Valuing Assets in Pension Plans; Lens Check; Conclusion: Asset Values in Bailouts; Appendix 2.1: Common Ratios, Multiples, Averages, and Algorithms Based on Assets - and Examples of Their Use Appendix 2.2: Asset -Based Approach to Business Valuation (American Society of Appraisers)Notes; Chapter 3: Valuation Based on Earnings (Income); Earnings Defined; Types of Earnings; Operating Earnings Are Key to Value; Earnings Are Relative to Revenues and Expenses; Earnings Are Ultimately Based on Assets; Hard Times Reveal Earnings-Asset Connection; How the Standard Setters Currently Define Earnings; A Brief Pause to Look at Our Compass; The Other Side of the Equation: Revenues Minus Expenses; How XBRL Can Connect the Dots between Earnings and Assets; Earnings Management and Fraud Earnings Caveat from a Sage |
| Record Nr. | UNISA-996218417003316 |
|
Monks Robert A. G.
|
||
| Hoboken, New Jersey : , : Bloomberg Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Corporate valuation for portfolio investment : analyzing assets, earnings, cash flow, stock price, governance, and special situations / / Robert A. G. Monks, Alexandra Reed Lajoux ; Foreword by Dean LaBaron
| Corporate valuation for portfolio investment : analyzing assets, earnings, cash flow, stock price, governance, and special situations / / Robert A. G. Monks, Alexandra Reed Lajoux ; Foreword by Dean LaBaron |
| Autore | Monks Robert A. G. |
| Edizione | [1st edition] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Bloomberg Press, , 2011 |
| Descrizione fisica | 1 online resource (579 p.) |
| Disciplina |
332.63221
658.15 |
| Collana | Bloomberg Financial |
| Soggetto topico |
Corporations - Valuation
Portfolio management |
| ISBN |
1-282-84905-0
1-283-10047-9 1-118-53186-8 9786612849053 9786613100474 1-118-02645-4 1-118-02646-2 0-470-88074-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Corporate Valuation for Portfolio Investment: Analyzing Assets, Earnings, Cash Flow, Stock Price, Governance, and Special Situations; Contents; Foreword; Preface; Acknowledgments; Chapter 1: Corporate Valuation for Portfolio Investment; Valuation Defined; The Importance of Equity; Equity Defined; Articles of Faith Undermined: Securitization at Risk; Benefits of the Equity Marketplace; The Flexible Nature of Equity Capital; Long-Term Superiority of Equity over Debt-with a Caution about Volatility; The Focused Nature of Valuation for Investment; Two Main Sources of Information about Equity
Financial Reports: Issues with GAAP and IFRS/IASSources of Complexity in Accounting for Company Value; Reforming GAAP and IFRS; The Problem of Fair Market Value: Reporting Values for Securities with No Current Market; Three Studies; The Need to Read between the Lines; Human Nature Complicates (but Also Informs) Equity Valuation; George Soros's Concept of Reflexivity; Other Paradoxes in Equity Investing; The Observer Effect; Human Nature as the Key to Equity Value; Need for Expression in Currency Values; On Financial Mathematics; In Closing: About This Book; A Range of Approaches; Notes Chapter 2: Valuation Based on AssetsOverview of Assets as a Unit of Valuation; An Opening Caveat: The Limitations of Accounting Numbers; Accounting Numbers: Why Assets as a Starting Point?; Definition of an Asset; Flow-Dominant vs. Value-Dominant Assets; The Market Premium and Nonmarket Discount; Bear Stearns: A Cautionary Tale; The Asset-Focused Investor; Current Asset Value; Taking Clues from Assets; The Sykes Model; Beyond Assets: Clues from Liabilities and Equity on the Balance Sheet; The Role of the Appraiser and Appraisal Standards in Valuing Assets; Fair Market Value Treatment Assets Fair Value of Assets Under FASB (GAAP) and IASB (IFRS)Valuing Intangible Assets on the Balance Sheet; Valuing Intangible Assets That Are Not on the Balance Sheet; Using the MD&A for Insights on Assets; Improvements in Fair Value Disclosures: A Checklist for Investors; Asset-Based Valuation by Industry; Special Topics in Asset Valuations: Valuing Assets in Pension Plans; Lens Check; Conclusion: Asset Values in Bailouts; Appendix 2.1: Common Ratios, Multiples, Averages, and Algorithms Based on Assets - and Examples of Their Use Appendix 2.2: Asset -Based Approach to Business Valuation (American Society of Appraisers)Notes; Chapter 3: Valuation Based on Earnings (Income); Earnings Defined; Types of Earnings; Operating Earnings Are Key to Value; Earnings Are Relative to Revenues and Expenses; Earnings Are Ultimately Based on Assets; Hard Times Reveal Earnings-Asset Connection; How the Standard Setters Currently Define Earnings; A Brief Pause to Look at Our Compass; The Other Side of the Equation: Revenues Minus Expenses; How XBRL Can Connect the Dots between Earnings and Assets; Earnings Management and Fraud Earnings Caveat from a Sage |
| Record Nr. | UNINA-9910829937103321 |
|
Monks Robert A. G.
|
||
| Hoboken, New Jersey : , : Bloomberg Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A course in Financial calculus / Alison Etheridge
| A course in Financial calculus / Alison Etheridge |
| Autore | Etheridge, Alison |
| Pubbl/distr/stampa | Cambridge : Cambridge University Press, 2002 |
| Descrizione fisica | viii, 196 p. : ill. ; 26 cm |
| Disciplina | 332.63221 |
| Soggetto topico |
Derivative securities - Prices - Mathematics
Business mathematics |
| ISBN | 0521890772 |
| Classificazione |
AMS 91-01
AMS 91B28 AMS 60G42 AMS 60H05 AMS 60J65 LC HG6024.A3E84 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991001555079707536 |
|
Etheridge, Alison
|
||
| Cambridge : Cambridge University Press, 2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Dividendos : personas físicas y morales / / José Pérez Chávez, Raymundo Fol Olguín
| Dividendos : personas físicas y morales / / José Pérez Chávez, Raymundo Fol Olguín |
| Autore | Pérez Chávez José |
| Edizione | [Segunda edición.] |
| Pubbl/distr/stampa | México, D.F. : , : Tax Editores Unidos, , 2015 |
| Descrizione fisica | 1 online resource (156 páginas) |
| Disciplina | 332.63221 |
| Soggetto topico |
Dividends - Mexico
Taxation - Mexico Tributación |
| Soggetto genere / forma | Libros electronicos. |
| ISBN | 607-440-785-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | spa |
| Record Nr. | UNINA-9910672074003321 |
|
Pérez Chávez José
|
||
| México, D.F. : , : Tax Editores Unidos, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dividends and dividend policy [[electronic resource] /] / H. Kent Baker
| Dividends and dividend policy [[electronic resource] /] / H. Kent Baker |
| Autore | Baker H. Kent (Harold Kent), <1944-> |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley, c2009 |
| Descrizione fisica | 1 online resource (555 p.) |
| Disciplina | 332.63221 |
| Altri autori (Persone) | BakerH. Kent <1944-> (Harold Kent) |
| Collana | The Robert W. Kolb series in finance |
| Soggetto topico |
Dividends
Corporate governance |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-36848-6
9786612368486 1-118-25840-1 0-470-47120-4 |
| Classificazione |
QC 240
QP 700 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Dividends and Dividend Policy; Contents; Acknowledgments; PART I: Dividends and Dividend Policy: History, Trends, and Determinants; CHAPTER 1: Dividends and Dividend Policy: An Overview; CHAPTER 2: The Historical Evolution of Dividends; CHAPTER 3: Trends in Dividends: Payers and Payouts; CHAPTER 4: Factors Influencing Dividends; CHAPTER 5: Cross-Country Determinants of Payout Policy: European Firms; PART II: Cash Dividends: Theoretical and Empirical Evidence; CHAPTER 6: Dividend Irrelevance Theory; CHAPTER 7: Residual Dividend Policy; CHAPTER 8: Taxes and Clientele Effects
CHAPTER 9: Agency Costs and the Free Cash Flow HypothesisCHAPTER 10: Asymmetric Information and Signaling Theory; CHAPTER 11: Behavioral Explanations of Dividends; CHAPTER 12: The Firm Life Cycle Theory of Dividends; CHAPTER 13: The Catering Theory of Dividends; PART III: Share Repurchases; CHAPTER 14: Stock Repurchases: Theory and Evidence, Part 1; CHAPTER 15: Stock Repurchases: Theory and Evidence, Part 2; CHAPTER 16: Stock Repurchases and Dividends: Trade-Offs and Trends; CHAPTER 17: Beating the Market with Share Buybacks; PART IV: Other Distribution Methods; CHAPTER 18: Special Dividends CHAPTER 19: Stock Splits, Stock Dividends, and Reverse Stock SplitsCHAPTER 20: Dividend Reinvestment Plans; PART V: Survey Evidence on Dividends and Dividend Policy; CHAPTER 21: Cash Dividends and Stock Repurchases; CHAPTER 22: Stock Splits, Stock Dividends, and Dividend Reinvestment Plans; CHAPTER 23: Why Individual and Professional Investors Want Dividends; PART VI: Other Dividend Issues; CHAPTER 24: Why Firms Begin Paying Dividends: Value, Growth, and Life Cycle Effects; CHAPTER 25: Dividend Policy and Corporate Governance; CHAPTER 26: Dividend Policy in Regulated Industries CHAPTER 27: Dividend Policy in a Global PerspectiveCHAPTER 28: Dividend Policy in Emerging Markets; Index |
| Record Nr. | UNINA-9910146412703321 |
|
Baker H. Kent (Harold Kent), <1944->
|
||
| Hoboken, NJ, : John Wiley, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dividends and dividend policy [[electronic resource] /] / H. Kent Baker
| Dividends and dividend policy [[electronic resource] /] / H. Kent Baker |
| Autore | Baker H. Kent (Harold Kent), <1944-> |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley, c2009 |
| Descrizione fisica | 1 online resource (555 p.) |
| Disciplina | 332.63221 |
| Altri autori (Persone) | BakerH. Kent <1944-> (Harold Kent) |
| Collana | The Robert W. Kolb series in finance |
| Soggetto topico |
Dividends
Corporate governance |
| ISBN |
1-282-36848-6
9786612368486 1-118-25840-1 0-470-47120-4 |
| Classificazione |
QC 240
QP 700 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Dividends and Dividend Policy; Contents; Acknowledgments; PART I: Dividends and Dividend Policy: History, Trends, and Determinants; CHAPTER 1: Dividends and Dividend Policy: An Overview; CHAPTER 2: The Historical Evolution of Dividends; CHAPTER 3: Trends in Dividends: Payers and Payouts; CHAPTER 4: Factors Influencing Dividends; CHAPTER 5: Cross-Country Determinants of Payout Policy: European Firms; PART II: Cash Dividends: Theoretical and Empirical Evidence; CHAPTER 6: Dividend Irrelevance Theory; CHAPTER 7: Residual Dividend Policy; CHAPTER 8: Taxes and Clientele Effects
CHAPTER 9: Agency Costs and the Free Cash Flow HypothesisCHAPTER 10: Asymmetric Information and Signaling Theory; CHAPTER 11: Behavioral Explanations of Dividends; CHAPTER 12: The Firm Life Cycle Theory of Dividends; CHAPTER 13: The Catering Theory of Dividends; PART III: Share Repurchases; CHAPTER 14: Stock Repurchases: Theory and Evidence, Part 1; CHAPTER 15: Stock Repurchases: Theory and Evidence, Part 2; CHAPTER 16: Stock Repurchases and Dividends: Trade-Offs and Trends; CHAPTER 17: Beating the Market with Share Buybacks; PART IV: Other Distribution Methods; CHAPTER 18: Special Dividends CHAPTER 19: Stock Splits, Stock Dividends, and Reverse Stock SplitsCHAPTER 20: Dividend Reinvestment Plans; PART V: Survey Evidence on Dividends and Dividend Policy; CHAPTER 21: Cash Dividends and Stock Repurchases; CHAPTER 22: Stock Splits, Stock Dividends, and Dividend Reinvestment Plans; CHAPTER 23: Why Individual and Professional Investors Want Dividends; PART VI: Other Dividend Issues; CHAPTER 24: Why Firms Begin Paying Dividends: Value, Growth, and Life Cycle Effects; CHAPTER 25: Dividend Policy and Corporate Governance; CHAPTER 26: Dividend Policy in Regulated Industries CHAPTER 27: Dividend Policy in a Global PerspectiveCHAPTER 28: Dividend Policy in Emerging Markets; Index |
| Record Nr. | UNINA-9910830561403321 |
|
Baker H. Kent (Harold Kent), <1944->
|
||
| Hoboken, NJ, : John Wiley, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
